Single-cell map of early stage lung cancer and normal lung sheds light on tumor development, new therapeutic targets
PARP inhibitor shrinks tumors in pancreatic cancer patients with mutations
10 May 2021Researchers map how people in cities get a health boost from nature
10 May 2021Single-cell map of early stage lung cancer and normal lung sheds light on tumor development, new therapeutic targets
Researchers at The University of Texas MD Anderson Cancer Center have developed a first-of-its-kind spatial atlas of early-stage lung cancer and surrounding normal lung tissue at single-cell resolution, providing a valuable resource for studying tumor development and identifying new therapeutic targets. The study was published today in Cancer Discovery, a journal of the American Association for Cancer Research.
